Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00527098 · ClinicalTrials.gov registry record

Optimal Fluid Resuscitation for Trauma Patients

A clinical trial, sponsored by University of Miami.

Completed
Registry status
119
Enrollment target

NCT00527098: Completed study, sponsored by University of Miami.

NCT00527098 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 119 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00527098 has completed, sponsored by University of Miami.

COMPLETED
Registry status
119 participants
Enrollment target

Study Summary

The purpose of this study is to determine if the overall fluid requirements for the first 24 hours after admission will be reduced with Hextend versus a standard of care crystalloid resuscitation fluid.

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2007-10
Est. Completion 2010-07
University of Miami

721 total trials

What the finished NCT00527098 record still lists

NCT00527098 is an observational study that tracks outcomes without assigning an intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00527098 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00527098 about?

NCT00527098 is a clinical study titled "Optimal Fluid Resuscitation for Trauma Patients". The purpose of this study is to determine if the overall fluid requirements for the first 24 hours after admission will be reduced with Hextend versus a standard of care crystalloid resuscitation fluid.

What is the current status of trial NCT00527098?

This trial is currently completed. The enrollment target is 119 participants. The study started on 2007-10. Estimated completion is 2010-07.

Who is sponsoring clinical trial NCT00527098?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04870762 · 119 participants · Phase 2

    Customized 3D Printed Oral Stents During Head and Neck Radiotherapy

  • NCT05559853 · 119 participants

    Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment

  • NCT06564389 · 119 participants · Phase 1

    FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

  • NCT06742801 · 119 participants · NA

    Onyx™ Liquid Embolic IDE Clinical Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00527098, the US trial registry maintained by the National Library of Medicine. NCT00527098 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.